Fortis stake sale: Latest bid 'more risky', says Manipal CEO Ranjan Pai as hospital mired in regulatory investigation
India’s privately held Manipal Hospitals had to take a “more risky” approach in its latest bid for domestic rival Fortis Healthcare to see off rival suitors, said Manipal’s Chief Executive Ranjan Pai.
Mumbai: India’s privately held Manipal Hospitals had to take a “more risky” approach in its latest bid for domestic rival Fortis Healthcare to see off rival suitors, Manipal’s Chief Executive Ranjan Pai told Reuters.
Manipal on Sunday sweetened its bid for Fortis, offering to inject Rs 21 billion ($312.8 million) to help the ailing hospital operator meet its immediate cash needs, a move that Pai said was risky because Fortis is embroiled in a regulatory investigation that is clouding its prospects.
In its previous bid Manipal and consortium partner TPG Capital had proposed to take over Fortis at the same valuation of Rs 160 rupees a share, or a total valuation of 83.58 billion rupees ($1.24 billion), without offering any initial cash injection.
“Yes, this is a more risky structure ... because we don’t know what’s going to come out of the SFIO,” Pai said on Monday, referring to India’s Serious Fraud Investigation Office.
The SFIO is investigating allegations that Fortis founders Malvinder Singh and Shivinder Singh took funds from the company. The duo, who have since left the company, deny wrongdoing.
In March, Fortis said it was looking into the allegations and that it expected the SFIO investigation to end in less than a year.
Fortis has been a target of five firms and investment groups vying for control of its 30-odd hospitals across India. Among them is Malaysia’s IHH Healthcare, which wants to invest as much as 40 billion rupees at 175 rupees a share, higher than the share price offered by Manipal.
Manipal did not want to be “irrational” in its bid, Pai said, adding that it brought a lot of value to Fortis and its investors with its experience in running hospitals and track record of providing good exit for private equity players.
“I think, beyond price, people have to look at what is good for the company in the medium to long term,” he said, adding that Manipal did not want to enter at a very high price and disappoint investors later if the share price falls.
Indian businessmen Sunil Munjal and Anand Burman have also offered to buy a stake in Fortis at 167 rupees a share as part of their offer totalling 18 billion rupees.
Radiant Life Care, backed by private equity firm KKR & Co and China’s Fosun International, are the other Fortis suitors.
Pai said he did not expect the deal to face antitrust hurdles because the combined company’s market share will be in “single digits” and a merger should take six to nine months to complete.
If a deal goes through, TPG will own about 14 percent the new Fortis, while Manipal’s founder company and other investors will together own 35.4 percent.
Pai said that Manipal has held talks with many of the long-term and major investors at Fortis.
“We want to assure them that if we are given control of the company, corporate governance levels and transparency will be at the highest.”
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
Fortis Healthcare demerger: Malaysia's IHH may table rival bid this week; minority shareholders might welcome offer
Malaysian investment holding company IHH Healthcare Bhd could make a rival offer for Fortis Healthcare Ltd in the coming days, valuing the Indian company at as much as $1.3 billion
Malaysia’s IHH Healthcare offers to buy Fortis at Rs 160 per share; trumps Munjal-Burman and Manipal
Fortis Healthcare said Malaysia’s IHH Healthcare Bhd has offered to buy company at 160 rupees per share, paving way to a better bid than Manipal Hospitals
Merger of Fortis Healthcare and Manipal Hospital Enterprises is expected to be completed in 10-12 months